National Legal News

Update: IVC Filter Bellwether Trials Scheduled

Update: IVC Filter Bellwether Trials Scheduled

Inferior vena cava (IVC) filters are small, spider-like devices that are implanted in patients who are at risk for developing severe blood clots. These filters are designed to catch clots in the bloodstream and break them apart before they are allowed to migrate to another part of the body and cause a stroke, myocardial infarction, or pulmonary embolism. These retrievable filters were intended to be placed in the body for only a short amount of time while the patient is in immediate danger. However, several studies have found that a large number of patients have suffered from serious complications after the device was left in the body for an extended period of time. Many of these injured patients have filed claims in the IVC filter lawsuit, and many of these individual claims have been consolidated into multidistrict litigation (MDL) actions. Recently, plaintiffs who have brought claims against Cook Medical have agreed to schedule the first IVC filter bellwether trials in Indiana, which are expected to begin in September 2016.

Xarelto® Lawsuit Update - Plaintiffs' Claims Supported by Scientific Studies

Xarelto® Lawsuit Update - Plaintiffs' Claims Supported by Scientific Studies

Invokana® Lawsuit Update: FDA Revises Warning Label

Invokana® Lawsuit Update: FDA Revises Warning Label

Invokana® belongs to a class of drugs called sodium-glucose cotransporter-2 (SGLT2) inhibitors, which are often recommended for patients with type 2 diabetes. These types of medications work by reducing the amount of glucose that is reabsorbed in the blood and increasing the amount of glucose that is excreted by the kidneys. When combined with a healthy diet and exercise, Invokana® is intended to help patients manage their condition and avoid dangerous fluctuations in their blood glucose levels. However, an increased incidence of potentially serious complications, such as diabetic ketoacidosis, kidney failure, and heart attacks, have caused many patients to file claims in the Invokana® lawsuit.

**Talcum Powder Lawsuit Update** $55 Million Jury Award

**Talcum Powder Lawsuit Update** $55 Million Jury Award